While growth is established for NYSE:HAE, the stock's valuation remains reasonable.

Take a closer look at HAEMONETICS CORP/MASS (NYSE:HAE), an affordable growth stock uncovered by our stock screener. NYSE:HAE boasts strong growth prospects and excels in financial health indicators, all while maintaining a reasonable valuation. Let's break it down further.

Growth Assessment of NYSE:HAE

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NYSE:HAE has received a 7 out of 10:

• The Earnings Per Share has grown by an nice 11.48% over the past year.
• HAE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.74% yearly.
• HAE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.85%.
• The Earnings Per Share is expected to grow by 21.40% on average over the next years. This is a very strong growth
• HAE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.74% yearly.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Evaluating Valuation: NYSE:HAE

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NYSE:HAE boasts a 6 out of 10:

• Compared to the rest of the industry, the Price/Earnings ratio of HAE indicates a rather cheap valuation: HAE is cheaper than 86.63% of the companies listed in the same industry.
• When comparing the Price/Earnings ratio of HAE to the average of the S&P500 Index (29.13), we can say HAE is valued slightly cheaper.
• 89.30% of the companies in the same industry are more expensive than HAE, based on the Price/Forward Earnings ratio.
• When comparing the Price/Forward Earnings ratio of HAE to the average of the S&P500 Index (23.71), we can say HAE is valued slightly cheaper.
• 85.03% of the companies in the same industry are more expensive than HAE, based on the Enterprise Value to EBITDA ratio.
• Based on the Price/Free Cash Flow ratio, HAE is valued a bit cheaper than 68.45% of the companies in the same industry.
• HAE has an outstanding profitability rating, which may justify a higher PE ratio.
• A more expensive valuation may be justified as HAE's earnings are expected to grow with 15.86% in the coming years.

Assessing Health Metrics for NYSE:HAE

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:HAE has received a 5 out of 10:

• HAE has a Altman-Z score of 2.85. This is in the better half of the industry: HAE outperforms 65.78% of its industry peers.
• HAE's Debt to FCF ratio of 39.37 is fine compared to the rest of the industry. HAE outperforms 67.91% of its industry peers.
• HAE has a Current Ratio of 3.49. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.
• HAE has a better Current ratio (3.49) than 62.03% of its industry peers.
• HAE has a Quick Ratio of 2.09. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.

Profitability Assessment of NYSE:HAE

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:HAE has earned a 9 out of 10:

• HAE has a better Return On Assets (4.90%) than 83.42% of its industry peers.
• With an excellent Return On Equity value of 14.09%, HAE belongs to the best of the industry, outperforming 88.77% of the companies in the same industry.
• HAE has a better Return On Invested Capital (7.59%) than 86.63% of its industry peers.
• The last Return On Invested Capital (7.59%) for HAE is above the 3 year average (7.51%), which is a sign of increasing profitability.
• The Profit Margin of HAE (9.10%) is better than 83.42% of its industry peers.
• In the last couple of years the Profit Margin of HAE has grown nicely.
• With an excellent Operating Margin value of 15.80%, HAE belongs to the best of the industry, outperforming 86.10% of the companies in the same industry.
• In the last couple of years the Operating Margin of HAE has grown nicely.
• HAE's Gross Margin has improved in the last couple of years.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of HAE

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.